Oncology/Hematology

Prostate Cancer

More in Prostate Cancer

Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

News, features, and commentary about cancer-related issues

Nov 15, 2024
Onco Break over a computer rendering of a cancer cell.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests

VA analysis finds men with limited life expectancy still getting aggressive treatment

Nov 11, 2024
A photo of a man being helped by a female healthcare worker following radiotherapy for prostate cancer.
'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer

News, features, and commentary about cancer-related issues

Nov 08, 2024
Onco Break over a computer rendering of a cancer cell.
Prostate Cancer Treatment Associated With Long-Term Complications

Researchers say inadequate understanding of risks may lead patients to regret treatment decisions

Nov 07, 2024
A photo of radiologists preparing a linear accelerator.
How Trump's Win Affects Healthcare; Uptick in COVID; Pesticides and Prostate Cancer

Health news and commentary gathered by staff

Nov 06, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

News, features, and commentary about cancer-related issues

Nov 01, 2024
Onco Break over a computer rendering of a cancer cell.
Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

-- News, features, and commentary about cancer-related issues

Oct 18, 2024
Onco Break over a computer rendering of a cancer cell.
Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

Odds of undetectable PSA at 48 weeks doubled with addition of Pluvicto

Oct 16, 2024
A computer rendering of prostate cancer.
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

News, features, and commentary about cancer-related issues

Oct 10, 2024
Onco Break over a computer rendering of a cancer cell.
Some Cancers Occur More Frequently in Multiple Sclerosis Patients

Bladder, brain, and cervical cancer risks were higher in people with MS

Oct 09, 2024
A computer rendering of nerve cells.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

"It really shows us that we have two great options," expert says

Sep 30, 2024
ASTRO over a photo of Walter E. Washington Convention Center in Washington, DC.
Happy People, Happy Hearts? Ultra-Processed Foods and Diabetes Risk

Also in TTHealthWatch: AACR report on cancer

Sep 28, 2024
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic

Actual rates for 2021 lagged behind projections

Sep 25, 2024
A photo of test tubes of blood lying on a test form with CANCER stamped in red at the bottom.
Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer

Strategy comes with associated "low risk" of delay in diagnosis of advanced or incurable cancers

Sep 25, 2024
An MRI image of a healthy prostate.
More in Prostate Cancer

1.50 CME Credits
Unleashing Emerging Therapies to Modify Myelofibrosis Pathogenesis: Shifting the Treatment Paradigm to Target Deeper Clinical and Molecular Responses

1.50 CME Credits
Accelerating the Adoption of the Latest Evidence on Sequencing Therapies for Multiple Myeloma Across Practice Settings

1.50 CME Credits
Treatment Crossroads: Diverse Perspectives on Treatment Strategies for Relapsed/Refractory DLBCL and FL

1.00 CME Credits
Decoding Complex Chronic Lymphocytic Leukemia Cases: An Expert TheraTalk

0.75 CME Credits
Ask the Experts: Latest Advances in Treatment of Low-Grade, Intermediate-Risk, Non-Muscle Invasive Bladder Cancer

1.00 CME Credits
Lung Cancer: Applying Evidence-Based Guidelines to Biomarker Driven Treatment Selection in Perioperative Settings

0.25 CME Credits
PARP Prodigy: Mastering Metastatic Castration-Resistant Prostate Cancer

0.75 CME Credits
The Latest Evidence and Barriers to the Integration of Emerging Targeted Therapies in Adult Diffuse Low-Grade Glioma Care